Tirzepatide (Injectable)

Yes. Tirzepatide is one of the medications Pepti requires recent bloodwork for before it is prescribed. Upload a recent lab report from any lab, or order Pepti's at-home panel; the physician reviews the results with your assessment.

Tirzepatide is a subcutaneous injection into the abdomen or thigh with a small insulin syringe. Your kit ships with sterile syringes and alcohol prep pads, and the exact dose and schedule are printed on the pharmacy label. Dosing videos are in your account.

One vial is your monthly supply at the dose your physician prescribes. A fresh vial ships about every 28 days, and the date moves if your physician changes your dose. Store it as the pharmacy label directs, refrigerated.

Once per fill, $159 each time, when the next vial ships. It renews until you cancel, which you can do anytime from your account with no cancellation fee.

The compounded Tirzepatide with sterile syringes and alcohol prep pads, free tracked shipping in an unbranded box with insulated packaging, the physician review, ongoing physician care and dose adjustments, and unlimited messaging.

Reported side effects of Tirzepatide are usually mild: nausea; diarrhea or constipation; fatigue; reduced appetite; heartburn. The physician screens your history, medications, and allergies before prescribing, the medication-specific consent lists the known risks, and you can message your physician about anything you notice. Seek emergency care for severe symptoms.

Response varies by person, goal, and dose, and Tirzepatide is prescribed for ongoing use rather than a short trial. Your physician sets expectations at approval, tracks how you respond through your account, and adjusts the dose without an appointment.

Yes, one step at a time. Tirzepatide moves up the pharmacy's strength ladder when your physician approves, and you pay the cost difference for the higher strength. It is never doubled.

Yes. Add Tirzepatide to a plan with another treatment and both go through one assessment and one physician review, shipping together on one schedule. Each keeps its own catalog price. The physician reviews the combination and can adjust it.

Compounded Tirzepatide is not FDA-approved. A brand-name form of the active ingredient is FDA-approved for specific indications; Pepti's version is compounded to your physician's prescription by an FDA-registered 503A pharmacy and prescribed off-label.

Yes, when prescribed by a licensed physician and dispensed by a licensed pharmacy, which is how Pepti provides it in every state it serves. Research-use-only Tirzepatide sold without a prescription is labeled not for human use and is a different product.

Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates both incretin pathways instead of just one. At Pepti it is prescribed to support dual gip/glp-1 action, superior weight loss, metabolic health, appetite reduction. Individual response varies, and your physician sets expectations at approval.

Tirzepatide is a dual GIP/GLP-1 receptor agonist — it activates both incretin pathways instead of just one. This dual action produces superior weight loss results vs semaglutide alone. Phase 3 trials showed up to 22.5% body weight loss. Compounded Tirzepatide is not FDA-approved; it is prescribed off-label by a licensed physician after reviewing your assessment.

Tirzepatide is prescribed for dual gip/glp-1 action, superior weight loss, metabolic health, appetite reduction. It is commonly requested by adults with a BMI in the range their physician considers appropriate for dual GIP/GLP-1 therapy; patients who did not reach their goal on semaglutide; people who want physician-managed dose escalation rather than a fixed dose; patients already on tirzepatide who want to continue at their current dose. Whether it is appropriate for you is the reviewing physician's decision.

Tirzepatide is studied for dual gip/glp-1 action, superior weight loss, metabolic health, appetite reduction. Those are the goals it is prescribed to support at Pepti; results vary by person, dose, and consistency, and no outcome is guaranteed. Your physician tracks how you respond through your account.

The SURMOUNT-1 trial (Jastreboff et al., NEJM 2022) randomized 2,539 adults with obesity to tirzepatide 5/10/15 mg vs placebo. At 72 weeks, mean weight reductions were 15.0%, 19.5%, and 20.9% on the active arms vs 3.1% on placebo — the highest weight-loss outcomes recorded for a pharmacological intervention at the time. SURMOUNT-2 confirmed efficacy in patients with type 2 diabetes, and the SURPASS program (Frias et al., 2021) demonstrated superior HbA1c reduction vs semaglutide head-to-head. Tirzepatide's dual GIP+GLP-1 mechanism appears to drive both stronger appetite suppression and improved metabolic flexibility. References are listed on this page.

Tirzepatide is generally not prescribed with: active cancer or history of cancer (unless approved by oncologist); pregnancy or breastfeeding; severe kidney or liver disease; known allergy to the peptide or excipients; medullary thyroid cancer history; men 2 syndrome. The physician screens for these in your intake, and anything that rules Tirzepatide out means it is not prescribed and is refunded.

At Pepti. Complete the free assessment, a physician licensed in your state reviews it within 4 hours, and if appropriate Tirzepatide is compounded by a state-licensed, FDA-registered pharmacy and shipped free to your door for $159 per month, all-in. Not prescribed means refunded.

Injectable vial: 2 mL, containing compounded to your dose Tirzepatide + included Glycine. One vial is your monthly supply at the prescribed dose, and a fresh one ships about every 28 days.

Not currently. Tirzepatide ships as a multi-dose vial with sterile syringes and prep pads. The pepti Pen is available for 10 other treatments.

$159 per month covers the compounded Tirzepatide, the physician review, ongoing physician care including dose adjustments and refill review, unlimited messaging, and free tracked shipping. There is no membership, consult, visit, or refill fee; the only separate charges are optional at-home lab panels and a physician-approved dose increase billed at pharmacy cost.

Yes. Tirzepatide is on Pepti's live catalog, which lists only treatments a partner pharmacy can compound and ship today. If a physician prescribes it, it ships; if it ever cannot be dispensed, the charge is refunded.

Tirzepatide ships to 50 states, free and tracked, in insulated unbranded packaging. Eligibility is confirmed during the assessment from your shipping address.

$159 per month at Pepti. That includes the compounded Tirzepatide, the physician review and ongoing care, free tracked shipping, and messaging, with no membership, consult, or visit fee. The price is the same in every state and every refill is the same price.

Pepti supplies Tirzepatide as a monthly injectable vial with syringes and prep pads included, one vial per month at $159, prescribed by a licensed physician after a free online assessment and shipped free from a state-licensed, FDA-registered pharmacy in insulated packaging.

Yes. Pepti prescribes Tirzepatide online in 50 states after a free assessment reviewed by a physician licensed in your state. It is compounded by an FDA-registered pharmacy and shipped free, $159 per month all-in. Not prescribed means refunded.

Yes. At Pepti the entire process is telehealth: a five-minute online assessment, recent bloodwork from any lab or an at-home panel, physician review within 4 hours, then Tirzepatide ships from the pharmacy. No clinic visit and no video appointment in most cases. $159 per month, all-in.

Yes, for the real thing. Tirzepatide sold without a prescription is research-use-only product labeled not for human use, with no physician, no pharmacy, and no verified testing. Pepti's Tirzepatide is physician-prescribed, pharmacy-compounded, batch-tested, and $159 per month including the physician and shipping.

Pepti does, in 50 states, with named board-certified physicians, a state-licensed FDA-registered compounding pharmacy, independent batch testing, and one published all-in price of $159 per month with no membership or consult fee. Refunded if the physician does not prescribe.

It is legal to be prescribed Tirzepatide online by a licensed physician and have it dispensed by a licensed pharmacy, which is how Pepti provides it. Buying it as a research chemical without a prescription is a different product and is not for human use. Compounded Tirzepatide is not FDA-approved; a brand-name form of the active ingredient is FDA-approved for specific indications.

$159 per month at Pepti, including the medication, the physician, and shipping. Refills are the same price and there is no membership fee.

Yes. Pepti has no clinics: the assessment, physician review, messaging, dose changes, and refills all happen online, and Tirzepatide ships free from the pharmacy to your door in 50 states.

Start the free assessment at hellopepti.com, choose Tirzepatide, and answer the health questions and upload recent labs or order the at-home panel. A physician licensed in your state reviews it within 4 hours. If approved, Tirzepatide ships within 1-3 business days and arrives in 1-3 more; if not, the $159 is refunded.

Yes. Tirzepatide is one of the medications Pepti requires recent bloodwork for. Upload a lab report from any lab, or order a Pepti at-home panel from $129; the physician reviews it with your assessment.

Pepti ships Tirzepatide to 50 states, free and tracked, refrigerated in insulated packaging, directly from the pharmacy. Delivery is 1-3 business days after the pharmacy compounds it.